Advertisement
Screener

ARIAD PHARMACEUTICALS INC Comprehensive Income

ARIAD PHARMACEUTICALS INC Comprehensive Income

ARIAD PHARMACEUTICALS INC reported Comprehensive Income of -$23.70 million for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-08.

Discontinued › Income Statement › Unrealized Gains

us-gaap:ComprehensiveIncomeNetOfTax · last filed 2016-11-08

  • ARIAD PHARMACEUTICALS INC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2016-09-30 was -$23.70M.
  • ARIAD PHARMACEUTICALS INC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2016-06-30 was $110.89M.
  • ARIAD PHARMACEUTICALS INC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2016-03-31 was -$57.75M.
  • ARIAD PHARMACEUTICALS INC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2015-12-31 was -$60.40M.
  • ARIAD PHARMACEUTICALS INC comprehensive income (loss), net of tax, attributable to parent for fiscal 2015 was -$223.14M.
  • ARIAD PHARMACEUTICALS INC comprehensive income (loss), net of tax, attributable to parent for fiscal 2014 was -$165.25M.
  • ARIAD PHARMACEUTICALS INC comprehensive income (loss), net of tax, attributable to parent for fiscal 2013 was -$275.71M.
  • ARIAD PHARMACEUTICALS INC comprehensive income (loss), net of tax, attributable to parent for fiscal 2012 was -$220.85M.
Period endComprehensive Income (Loss), Net of Tax, Attributable to Parent 3 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 6 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 9 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month
2016-09-30-$23.70M
10-Q · filed 2016-11-08
$87.19M
derived: sum of 2 quarters · filed 2016-11-08
$29.44M
10-Q · filed 2016-11-08
-$30.96M
derived: sum of 4 quarters · filed 2016-11-08
2016-06-30$110.89M
10-Q · filed 2016-08-08
$53.14M
10-Q · filed 2016-08-08
-$7.26M
derived: sum of 3 quarters · filed 2016-08-08
-$53.91M
derived: sum of 4 quarters · filed 2016-11-08
2016-03-31-$57.75M
10-Q · filed 2016-05-10
-$118.15M
derived: sum of 2 quarters · filed 2016-05-10
-$164.79M
derived: sum of 3 quarters · filed 2016-11-08
-$228.53M
derived: sum of 4 quarters · filed 2016-11-08
2015-12-31-$60.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
-$107.04M
derived: sum of 2 quarters · filed 2016-11-08
-$170.78M
derived: sum of 3 quarters · filed 2016-11-08
-$223.14M
10-K · filed 2016-02-29
2015-09-30-$46.64M
10-Q · filed 2016-11-08
-$110.38M
derived: sum of 2 quarters · filed 2016-11-08
-$162.74M
10-Q · filed 2016-11-08
-$171.38M
derived: sum of 4 quarters · filed 2016-11-08
2015-06-30-$63.73M
10-Q · filed 2016-08-08
-$116.09M
10-Q · filed 2016-08-08
-$124.74M
derived: sum of 3 quarters · filed 2016-08-08
-$174.69M
derived: sum of 4 quarters · filed 2016-08-08
2015-03-31-$52.36M
10-Q · filed 2016-05-10
-$61.01M
derived: sum of 2 quarters · filed 2016-05-10
-$110.96M
derived: sum of 3 quarters · filed 2016-05-10
-$167.83M
derived: sum of 4 quarters · filed 2016-05-10
2014-12-31-$8.64M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
-$58.59M
derived: sum of 2 quarters · filed 2016-02-29
-$115.47M
derived: sum of 3 quarters · filed 2016-02-29
-$165.25M
10-K · filed 2016-02-29
2014-09-30-$49.95M
10-Q · filed 2015-11-06
-$106.83M
derived: sum of 2 quarters · filed 2015-11-06
-$156.61M
10-Q · filed 2015-11-06
-$232.28M
derived: sum of 4 quarters · filed 2016-02-29
2014-06-30-$56.88M
10-Q · filed 2015-08-07
-$106.66M
10-Q · filed 2015-08-07
-$182.33M
derived: sum of 3 quarters · filed 2016-02-29
-$248.68M
derived: sum of 4 quarters · filed 2016-02-29
2014-03-31-$49.78M
10-Q · filed 2015-05-08
-$125.45M
derived: sum of 2 quarters · filed 2016-02-29
-$191.80M
derived: sum of 3 quarters · filed 2016-02-29
-$260.84M
derived: sum of 4 quarters · filed 2016-02-29
2013-12-31-$75.67M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
-$142.02M
derived: sum of 2 quarters · filed 2016-02-29
-$211.06M
derived: sum of 3 quarters · filed 2016-02-29
-$275.71M
10-K · filed 2016-02-29
2013-09-30-$66.35M
10-Q · filed 2014-11-07
-$135.39M
derived: sum of 2 quarters · filed 2014-11-07
-$200.04M
10-Q · filed 2014-11-07
-$260.49M
derived: sum of 4 quarters · filed 2015-03-02
2013-06-30-$69.04M
10-Q · filed 2014-08-08
-$133.69M
10-Q · filed 2014-08-08
-$194.15M
derived: sum of 3 quarters · filed 2015-03-02
-$247.34M
derived: sum of 4 quarters · filed 2015-03-02
2013-03-31-$64.65M
10-Q · filed 2014-05-09
-$125.11M
derived: sum of 2 quarters · filed 2015-03-02
-$178.30M
derived: sum of 3 quarters · filed 2015-03-02
-$229.59M
derived: sum of 4 quarters · filed 2015-03-02
2012-12-31-$60.45M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02
-$113.64M
derived: sum of 2 quarters · filed 2015-03-02
-$164.94M
derived: sum of 3 quarters · filed 2015-03-02
-$220.85M
10-K · filed 2015-03-02
2012-09-30-$53.19M
10-Q · filed 2013-11-12
-$104.49M
derived: sum of 2 quarters · filed 2013-11-12
-$160.40M
10-Q · filed 2013-11-12
-$212.20M
derived: sum of 4 quarters · filed 2014-03-03
2012-06-30-$51.30M
10-Q · filed 2013-08-09
-$107.21M
10-Q · filed 2013-08-09
-$159.01M
derived: sum of 3 quarters · filed 2014-03-03
-$145.10M
derived: sum of 4 quarters · filed 2014-03-03
2012-03-31-$55.91M
10-Q · filed 2013-05-10
-$107.71M
derived: sum of 2 quarters · filed 2014-03-03
-$93.80M
derived: sum of 3 quarters · filed 2014-03-03
-$141.56M
derived: sum of 4 quarters · filed 2014-03-03
2011-12-31-$51.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03
-$37.89M
derived: sum of 2 quarters · filed 2014-03-03
-$85.65M
derived: sum of 3 quarters · filed 2014-03-03
-$123.60M
10-K · filed 2014-03-03
2011-09-30$13.91M
10-Q · filed 2012-11-09
-$33.85M
derived: sum of 2 quarters · filed 2012-11-09
-$71.80M
10-Q · filed 2012-11-09
2011-06-30-$47.76M
10-Q · filed 2012-08-09
-$85.71M
10-Q · filed 2012-08-09
2011-03-31-$37.95M
10-Q · filed 2012-05-09
2010-12-31$85.25M
10-K · filed 2013-03-01
2009-12-31-$80.03M
10-K/A · filed 2012-03-30